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ANALYSIS OF STUDIES IN THE FIELD OF WASTEWATER POLLUTION  
BY PHARMACEUTICAL CONTAMINANTS 
 
The analysis of recent studies of surface waters pollution problem by pharmaceuticals and their derivatives 
was performed. The information about the sources of contaminated effluents formation, especially their negative 
impact on the elements of the environment, purification at municipal wastewater treatment plants was systema-
tized. Measures of environmental pollution reduction were considered. The authors made the conclusions about 
the study degree of this problem and ways of this solving. 
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Самойленко Н. М., Єрмакович І. А. АНАЛІЗ ДОСЛІДЖЕНЬ У СФЕРІ ЗАБРУДНЕННЯ 
СТІЧНИХ ВОД ФАРМАЦЕВТИЧНИМИ ПОЛЛЮТАНТАМИ 
Проведено аналіз останніх досліджень актуальної проблеми забруднення поверхневих вод фармацев-
тичними препаратами та їх похідними. Систематизовані відомості про джерела формування забруднених 
стоків, особливості їх негативного впливу на елементи навколишнього середовища, очищення на муні-
ципальних очисних спорудах. Розглянуто заходи щодо зниження забруднення навколишнього середови-
ща. Авторами статті зроблено висновки про ступінь дослідженості даної проблеми і про напрямки її ви-
рішення 
Ключові слова: стічні води, фармацевтичні забруднювачі, очищення, екотоксикологія 
 
Самойленко Н. Н., Ермакович И. А. АНАЛИЗ ИССЛЕДОВАНИЙ В СФЕРЕ ЗАГРЯЗНЕНИЯ 
СТОЧНЫХ ВОД ФАРМАЦЕВТИЧЕСКИМИ ПОЛЛЮТАНТАМИ 
Проведен анализ последних исследований актуальной проблемы загрязнения поверхностных вод 
фармацевтическими препаратами и их производными.  Систематизированы сведения об источниках 
формирования загрязненных стоков, особенностях их негативного влияния на элементы окружающей 
среды, очистки на муниципальных очистных сооружениях. Рассмотрены мероприятия по снижению за-
грязнения окружающей среды. Авторами статьи сделаны выводы о степени исследованности данной 
проблемы и о направлениях ее решения 
Ключевые слова: сточные воды, фармацевтические загрязнители, очистка, экотоксикология 
 
 
Introduction 
Nowadays, scientists around the world 
have been studied uncontrolled and continuous 
releasing pharmaceuticals into the environment 
and the consequences of their impact on the nat-
ural living organisms for decades. Recent data 
suggest that this leads to negative changes in its 
components and violate the natural processes in 
the ecosystem sustainability. The greatest con-
cern is the pollution of wastewater containing 
pharmaceuticals and their derivatives. Accord-
ing to this, the prevention of the release of these 
compounds into environment is extremely rele-
vant point, mostly in the developed countries 
[1]. 
The purpose of the research: to define 
the level of the studied problem related to envi-
ronmental pollution by pharmaceutical residues 
coming into wastewater as well as trends of it 
solution. 
Problem Statement: -to identify the de-
gree of influence of pharmaceutical pollutants 
on the environment, in micro- and nano- quanti-
ties based on the analysis of modern publica-
tions by foreign authors; 
- to make conclusions about the available 
results and trends for the further research. 
____________________________ 
© Самойленко Н. М., Єрмакович І. А., 2014 
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1. The main sources of pharmaceuticals pollutants in wastewaters 
The quantity of drugs consuming by the 
population is extremely large. Only in 2013, the 
Ukrainian pharmacies sold 1.3 billion of medi-
cines packages, which is 28 units of such pack-
ages per an Ukrainian citizen [2]. There are non-
steroidal anti-inflammatory drugs among them 
(NSAIDs) which are daily worldwide used by 
more than 30 million of consumers. At the same 
time, for example, in the United States only 
more than 1 billion of NSAID of recipes is pre-
scribed annually [3].  
Insufficiently treated wastewaters from 
hospitals, pharmaceutical companies, domestic 
sewage and wastewater veterinary clinics and 
livestock farms are considered  as the main 
sources of pharmaceuticals entering into the sur-
face waters.  
Unfortunately, only a small part of the 
unused expired or substandard drugs is gathered 
to be disposed or incinerated. However, a large 
part, in the form of original drugs or metabo-
lites, is discarded to waste disposal site or 
flushed down via toilet into municipal sewer in 
excrement (removing with urine, feces and 
sweat). For example, the annual consumption of 
drug Diclofenac by some EU residents could be 
78 579 kg/year (Germany, 2010), 22 640 
kg/year (France, 2010) [4]. 
Obviously, the source of the formation 
and entering of such pollutants into municipal 
wastewater are is? accounted for hospitals. Lit-
erature data indicate that the hospital 
wastewaters have 15 times higher potential eco-
toxicity than general municipal ones. For exam-
ple, in Germany there are more than 12 000 tons 
of drugs that are disposed through the toilet or in 
the form of general household waste [5, 6]. The 
data of the concentrations of some pharmaceuti-
cals in different types of wastewaters is shown 
in Table 2. 
Table 2 
Concentrations of priority pharmaceuticals in hospital wastewaters 
Name of the 
drug 
Concentration in 
effluent hospitals 
in Europe, µg/l 
Concentration in 
effluent hospitals 
in Sweden, µg/l 
Calculated  
concentration in 
effluent hospitals 
in Ukraine, µg/l 
Concentration of 
entering wastewater 
into MSTP in Eu-
rope, µg/l 
Diclofenac 70
 
0,38 2,2 10
 
в-estradiol 0,23 0,017 n.d. 0,114 
Atenolol 122 1,2 0,325 0,800
 
Furosemide 21,48 
*
n.d. 6,2 2,214 
Cefurotoxime >125
 *
n.d. 64,23 0,125 
*
n.d. 
2.  Pharmaceutical pollutants effect on environment 
2.1 Effect of pharmaceuticals mix 
The most of the scientific publications 
concerning pharmaceuticals influence on living 
organisms deal with only one drug, losing the 
summation effect, which has a negative impact. 
However, the study [7] indicates that the micro 
pollutants of multicomponent pharmaceutical 
mixture may interact with each other. Thus, this 
provides an integrated toxicity on organisms. 
For example, the study of diclofenac, ibuprofen, 
naproxen and aspirin interaction in water 
demonstrates a synergistic toxicity.  
Most number of recent studies show that 
the pharmaceuticals and their derivatives, in-
cluding many of therapeutic groups such as an-
tibiotics, analgesics, anticancer, contraceptives 
and antidepressants has a sufficient environmen-
tal toxic effect [8]. 
2.2. Ecotoxicological effect 
Pharmaceuticals could also cause negative 
effects on organisms living in the soil, such as 
bacteria, fungi and others earthworms through 
the sewage sludge, which is often used for ferti-
lization [9]. 
The most bright example of failed using 
of diclofenac for treatment animals was shown 
in study [10] where 99,9% of the vulture popula-
tion in the Indian subcontinent had died by 
2008. The mechanism is presumed to be renal 
failure, a known side effect of diclofenac. Vul-
tures eat the carcasses of livestock that have 
been administered veterinary diclofenac, and are 
poisoned by the accumulated chemical, as vul-
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tures do not have a particular enzyme to break 
down the diclofenac.  
Five different antibiotics such as ciprof-
loxacin, norfloxacin, ofloxacin, sulfamethoxine, 
and sulfamethoxasole were detected during the 
research of sludge from sewage treatment plant 
in Lithuania. Some of them were also found 
mainly in carrots and potatoes in 10-100 times 
lower concentrations than in the soil [11]. Of-
loxacin and sulfadimethoxine were also detected 
in wheat. Ofloxacin was accumulated 5 times in 
the wheat seeds compared to the concentration 
in the soil. According to the experiments, it was 
made the conclusion that there is a real risk of 
antimicrobials uptaking into crops and the expo-
sure to humans [12]. 
The study of a diclofenac, ibuprofen, 
naproxen and acetylsalicylic acid acute toxicity  
mixture to the crustacean D.magna as well as 
green algae D. subspicatus in a 48 h test was 
shown in [13]. The main conclusion of this 
study is that the single compound does not have 
any significant concentration effect. The nega-
tive effect is observed only when these sub-
stances are mixed.  
In another investigation of the freshwater 
the amphipod H. Azteca was exposed by 
0,2 µg/L mixture concentration of seven phar-
maceuticals such as paracetamol, diclofenac, 
gemfibrozil, ibuprofen, naproxen, salicylic acid 
and triclosan [14]. The main criteria were sur-
vival, mating, body size and reproduction. All of 
them were negatively influenced by the mixture.  
In the research of biomarker cytogenotox-
ic effects [15], freshwater bivalve D.polymorpha 
was investigated with different concentrations 
1.5, 9, 13 µg/l of the diclofenac, ibuprofen and 
paracetamol mixture for 96 h. The results 
demonstrated that all 3 concentrations produced 
a considerable destabilization of the lyzosomal 
membranes and cellular stress in 72 h. DNA 
fragmentation increasing was observed in 24 h.  
3. The treatment contaminated effluents at the MSTP 
The main reason of getting pharmaceu-
ticals and their derivatives into the surface wa-
ters is the lack of an effective biological treat-
ment at the MSPT. Table 3 shows the cleaning 
data at wastewater treatment plants containing 
these contaminants. 
Table 3  
The purification factor of the sewage at MSTP containing pharmaceutical pollutants 
Name of the drug Concentration of entering wastewater  
into MSTP in Europe, µg/l 
Purification factor at MSTP, 
% 
Diclofenac 10 34 
в-estradiol 0,114 30 
Atenolol 0,800 71 
Furosemide 2,214 42 
Cefurotoxime 0,125 n.d.
* 
*
n.d.- no data 
The authors [16] explain such a low rate 
of treatment by two factors. Firstly, the concen-
tration of the mostly detected pharmaceuticals is 
extremely low. This leads to the fact that micro-
organisms of the activated sludge are not able to 
catch molecule of the chemical compounds of 
the drugs. Secondly, annually new types of med-
icines that belong to the new group of pharma-
ceuticals are getting on market, to which the 
microbiota of activated sludge cannot adapt.  
Chemical substances of pharmaceutical 
pollutants can poison the living community of 
activated sludge at MSTP. The study of the acti-
vated sludge microorganisms reactions to the 
pharmaceuticals toxic effects allows forecast 
negative changes in biological nature. Hence, it 
may have the impact to the wastewater treatment 
results. It becomes especially relevant during 
any flu epidemic, when the number of pharma-
ceutical pollutants getting into municipal sewage 
significantly increase. The paper [17] highlights 
the destabilization risk of the activated sludge 
when it is exposed to this period of biologically 
active pharmaceuticals. The investigation of ac-
tivated sludge from treatment facilities helps to 
establish the degree of the degradation of hor-
monal substances that are contained in effluent. 
Thereby, the paradoxical fact was established. It 
determined that the products of its biodegrada-
tion can be even more harmful (dangerous) than 
the "parent" original compound [18]. 
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Now, pharmaceuticals are considered as 
emerging microcontaminants in the treated 
wastewaters and as storages in the activated 
sludge. According to the research [19] water and 
sludge from biological treatment should not be 
used in agriculture, especially if these waters 
contain antibiotics. Pharmaceutical contami-
nants and their derivatives have a variety of 
negative effects on activated sludge. Some of 
them slow down oxygen consumption of acti-
vated sludge and reduces its productivity while 
others could be the food for them. The formed 
conglomerates of the sludge with pharmaceuti-
cal pollutants can effect on the rate of oxygen 
uptake and negatively affect its condition. 
The chemical composition of pharmaceu-
ticals varies significantly during their interaction 
with activated sludge. Particularly, this is ex-
pressed by example of drug "hardness" that is 
connected with the complex chemical formula 
(for example, carbamazepine, diclofenac and 
others). Furthermore, it is an important biologi-
cal effect of the drug on the biocenosis and 
sludge, the presence of active chlorine mole-
cules in it. 
4. Measures for the pharmaceuticals pollution reduction in environment 
4.1 Legislative level 
Taking into account the existing problem 
connected with the fact that the European Com-
mission of the EU Water Framework Directive 
has put 3 pharmaceuticals in the list of priority 
substances with controlling discharge into envi-
ronment [20] (table 3). 
Table 3 
List of priority pharmaceuticals in the field of water policy under the Water Framework 
Directive of the European Union (2000/60 / EC) 
Name of Pharmaceuti-
cals 
 
CAS
2
 number Annual average 
ENVIRONMENTAL 
QUALITY STANDARDS 
(EQS), Inland surface waters
1
, 
µg/l 
Maximum allowable con-
centration 
EQS, other surface waters, 
µg/l 
17alpha-ethinylestradiol 57-63-6 3,5 х 10-5 7 х 10-6 
17beta-estradiol 50-28-2 4 х 10-4 8 х 10-5 
Diclofenac 15307-79-6 0,1 0,01 
1
Inland surface waters encompass rivers and lakes and related artificial or heavily modified water bodies 
2
CAS: Chemical Abstracts Service 
 
Unfortunately, now in Ukraine pharma-
ceutical substances are not included in any nor-
mative documents for wastewater discharges. In 
addition, it does not carry out any monitoring or 
control. 
4.2 Engineering methods 
Current analysis of the information 
sources demonstrates that there is no universal 
method for purification of wastewater contain-
ing various contaminants and allowing produce 
their disinfection with high cleaning degree in a 
single process. Moreover, the efficiency of 
wastewater treatment by the same drug may 
have significant differences. For example, the 
removal efficiency of Diclofenac on standard 
treatment plants varies from 17% to 69%. Thus, 
at wastewater treatment plant - Collybia in Swe-
den, it is 22% [20]. 
The removal of pharmaceutical pollutants 
are basically regarded as purification of water 
from organic substances. There is a great variety 
of these kinds of pollutants disposal methods. 
Many of them are widely known and have been 
used for organic compounds removing from in-
dustrial and municipal wastewater for a long 
time. However, their purification efficiency is 
usually not satisfactory because even mi-
croquantities of pharmaceutical substances in 
the waters have a significant negative impact on 
the environment. Other similar methods and 
techniques that are relevant to the new develop-
ments usually have certain limitations or draw-
backs. It holds back their implementation (Fen-
ton - photocatalytic method, supercritical tech-
nology and etc). Existing combined processes in 
which the oxidation reagent and further biodeg-
radation are applied are quite expensive from an 
economic point of view. A very perspective wa-
ters purification by reverse osmosis cannot be 
applied to wastewater containing some com-
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monly used hard degradable drugs. Wastewater 
treatment from antibiotics, cholesterol, bi-
sphenol A to 93-99% at MSTP leads to the fact 
that the concentration of contaminants is re-
duced to 223 ng / l. It is not enough of getting a 
complete effect from the treatment [21].  
Publications about wastewater treatment 
from the mixtures of pharmaceutical pollutants 
are not found. 
Conclusion 
1. Pharmaceutical contaminants, which 
are found in residual concentrations in the 
wastewaters, entering into treatment plant, pass-
ing through cleaning process, are not always 
completely decomposed. Moreover, they could 
cause negative changes into environment. The 
content of analysis shows that the study of 
pharmaceutical wastewaters pollutants impact 
on the environment is mostly researched by Eu-
ropean scientists. They are performing the ana-
lytical tests of these pollutants presence both in 
municipal wastewaters and surface waters. 
Based on the results of the EU at the normative 
level, they are making the control of priority 
pollutants dumping into environment. It is ap-
propriate to use this approach for the waters 
monitoring in Ukraine as well. 
2. Most of the residues of pharmaceutical 
pollutants demonstrate the effect of summation 
in relation to the toxicity effects on organisms in 
effluents. Diclofenac, Beta-estradiol, Cefurox-
ime and others are the source of ecotoxicity. 
3. The effect of residual drugs on activat-
ed sludge from treatment facilities can lead to 
poor treatment performance due to the toxicity 
effects on biota. It is noted that some of the 
products of biodegradation could be more harm-
ful than the original contaminants are. In gen-
eral, the effect of the active pharmaceutical sub-
stances on a sludge will depend on its chemical 
structure, as well as the presence of biological 
effects. 
4. Modern engineering methods of 
wastewater treatment from residuals of medi-
cines do not provide the required criteria. Fur-
thermore, there are no studies performed in a 
single neutralization process of effluents con-
taining pharmaceutical mixture characterized for 
wastewaters of medical establishments. There-
fore, scientists are searching for the most effec-
tive and economically appropriate method for 
solving this urgent problem, which requires 
combining efforts of specialists from different 
fields. 
This study was carried out with the sup-
port of CENEAST (reformation of the Curricula 
on Built Environment in the Eastern Neighbour-
ing Area) of the European Commission. The 
conclusions and opinions expressed in this doc-
ument reflect the views of the authors only and 
the Commission is not responsible for the in-
formation contained there. 
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